SCHEMBL3710792

SCHEMBL3710792

CCCCCCCCCCCCCC=CC(=O)OC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.51
PPARA Q07869 5/20 0.51
CNR1 P21554 1/20 0.51
CNR2 P34972 1/20 0.51
TERT O14746 3/20 0.50
PTPN1 P18031 3/20 0.50
PPARD Q03181 3/20 0.50
CYP1A2 P05177 2/20 0.50
MAPT P10636 2/20 0.50
CYP2C19 P33261 2/20 0.50
BLM P54132 2/20 0.50
HSD17B10 Q99714 2/20 0.50
FABP4 P15090 2/20 0.50
FAAH O00519 2/20 0.50
KMT2A Q03164 2/20 0.50
GMNN O75496 1/20 0.50
USP2 O75604 1/20 0.50
LMNA P02545 1/20 0.50
POLB P06746 1/20 0.50
CYP2C9 P11712 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5452957 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL864034 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL2342147 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL11743976 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL14672999 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL874683 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL347470 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL22555434 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL22555479 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL7902650 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025090952-A1 DESATURASE VARIANTS AND METHODS OF USE GENOMATICA, INC. (US) 2025-05-01 WO claimed
CN-113698293-B High-purity algae-derived PLA and preparation method thereof 中国科学院大连化学物理研究所 2022-09-02 CN claimed
EP-4049994-A1 ESTER COMPOUND AND PREPARATION METHOD THEREFOR AND USES THEREOF China Petroleum & Chemical Corporation (CN) 2022-08-31 EP claimed
CN-113698293-A High-purity algae-derived PLA and preparation method thereof 中国科学院大连化学物理研究所 2021-11-26 CN claimed
CN-112707834-A Ester compound and preparation method and application thereof 中国石油化工股份有限公司 2021-04-27 CN claimed
CN-120138067-A Application of silkworm fatty acid dehydrogenase Bmdesat13 in enzymatic catalysis of trans-palmitoleic acid production and method 西南大学 2025-06-13 CN disclosed
WO-2025090952-A1 DESATURASE VARIANTS AND METHODS OF USE GENOMATICA, INC. (US) 2025-05-01 WO disclosed
CN-119859109-A Preparation method and application of organic amide friction modifier 中国石油天然气股份有限公司 2025-04-22 CN disclosed
US-12263181-B2 Phospholipid compositions MACHAVERT PHARMACEUTICALS LLC (US) 2025-04-01 US disclosed
US-20230332096-A1 METHODS AND CELL FACTORIES FOR PRODUCING INSECT PHEROMONES BIOPHERO APS (DK) 2023-10-19 US disclosed
CN-116640612-A Fuel additive, preparation method thereof and fuel composition 中国石油化工股份有限公司 2023-08-25 CN disclosed
US-20230012456-A1 ESTER COMPOUND AND PREPARATION METHOD THEREFOR AND USES THEREOF RESEARCH INSTITUTE OF PETROLEUM PROCESSING, SINOPEC (CN) 2023-01-12 US disclosed
US-6005134-A REACTING ALIPHATIC CARBOXYLIC ACID, LOWER ALKYL ESTER THEREOF OR FATTY ACID GLYCERIDE WITH AMMONIA IN THE PRESENCE OF COMPOSITE OXIDE CATALYST COMPRISING TITANIUM OXIDE AS THE MAIN COMPONENT KAO CORPORATION (JP) 1999-12-21 US disclosed
EP-0948963-A1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness Fideline (FR) 1999-10-13 EP disclosed
WO-1999037297-A1 PIG APPEASING PHEROMONES TO DECREASE STRESS, ANXIETY AND AGGRESSIVENESS FIDELINE (FR) 1999-07-29 WO disclosed
US-5883206-A Free radical polymer chain initiation with unreactive unsaturates E. I. DU PONT DE NEMOURS AND COMPANY (US) 1999-03-16 US disclosed
EP-0888388-A1 FREE RADICAL POLYMER CHAIN INITIATION WITH UNREACTIVE UNSATURATES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1999-01-07 EP disclosed
US-5856196-A RESPIRATORY SYSTEM DISORDERS BETH ISRAEL HOSPITAL (US) 1999-01-05 US disclosed
WO-1997034934-A1 FREE RADICAL POLYMER CHAIN INITIATION WITH UNREACTIVE UNSATURATES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1997-09-25 WO disclosed
US-4472432-A ANTIDIABETIC, ANTILIPEMIC AGENTS INABATA & CO., LTD. (JP) 1984-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12263181-B2 Phospholipid compositions PHOSPHO1, SGMS1, SGMS2 PPARG 3337/4885PPARA 3072/4885CNR1 2784/4885
US-20230012456-A1 ESTER COMPOUND AND PREPARATION METHOD THEREFOR AND USES THEREOF ALOX12, FAR1, ALOX15 PPARG 732/4885PPARA 329/4885CNR1 3294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.